Sign in

CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Drugs Made In America Acquisition II Corp.

Sign in to watch
Ticker
DMII
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
954-870-3104
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMII Ordinary Shares Nasdaq
  • DMIIR Right Nasdaq
  • DMIIU Unit Nasdaq
  1. 4 Other acquisition Director acquired 100,000 shares (other)
  2. 4 Other acquisition Director acquired 100,000 shares (other)
  3. 4 Other acquisition CFO acquired 100,000 shares (other)
  4. 4 Open-market buy CEO and Exe. Chair of Board bought 700,000 shares
  5. 4 Open-market buy 10% owner bought 700,000 shares
  6. 4 Other acquisition Director acquired 100,000 shares (other)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 12 filings